Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis in New Zealand Māori.
Calcium intervention ameliorates experimental model of multiple sclerosis.
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
High-resolution melting analysis for mutation scanning in the non-coding control region of JC polyomavirus from patients with progressive multifocal leukoencephalopathy.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Effects of whole body vibration on muscle spasticity for people with central nervous system disorders: A systematic review.
Improved spatial regression analysis of diffusion tensor imaging for lesion detection during longitudinal progression of multiple sclerosis in individual subjects.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors.
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
Mortality in patients with multiple sclerosis.
Animal models for human herpesvirus 6 infection.
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Relapsing optic neuritis: a multicentre study of 62 patients.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Pages
« first
‹ previous
…
470
471
472
473
474
475
476
477
478
…
next ›
last »